Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $13.6000 (2.41%) ($13.6000 - $13.6000) on Wed. May. 26, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.56% (three month average) | RSI | 56 | Latest Price | $13.6000(2.41%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.5% a day on average for past five trading days. | Weekly Trend | BCRX advances 4.2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(45%) IBB(40%) IWO(37%) ARKG(35%) ARKK(35%) | Factors Impacting BCRX price | BCRX will decline at least -2.78% in a week (0% probabilities). VIXM(-22%) UUP(-14%) VXX(-7%) IGOV(-2%) TBT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.78% (StdDev 5.56%) | Hourly BBV | 0.1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $13.66(-0.44%) | 10 Day Moving Average | $13.6(0%) | 20 Day Moving Average | $12.8(6.25%) | To recent high | -5.6% | To recent low | 43.2% | Market Cap | $2.399b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |